Home/Publication/Kantharos Capital Funds Cell Therapy in Singapore
Kantharos Capital Funds Cell Therapy in Singapore 

23 Jul 2026

US$ 20.00

Kantharos Capital has led the US$8 m series A financing of the Singapore-based Tikva Allocell Pte Ltd (Tikva), a...

Price / article: US$20.00
OR existing subscriber
Related Publications

Subscribers’ Weekly for the week ending 24 July 2026...

Listen to Southeast Asia Investments (Subscribers' Weekly 24 Jul 2026)...

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.